Skip to content
Health News

Oxford-AstraZeneca Covid jab safe, insists Hancock

By health | March 17, 2021
0 Comment

[unable to retrieve full-text content]People should “get the jab”, the health secretary says, after some countries suspend its use.
BBC News – Health

Category: Advertising & Marketing Tags: COVID, Hancock, insists, OxfordAstraZeneca, Safe
Post navigation
← Gundry MD 24 Strain Probiotic Review 2021 – Probiotic For Digestive Support Transparency watchdog criticizes STAT’s non-disclosure on pro-Pharma op-ed →
  • Here’s How Mark Cuban Would Make It As a 20-Year-Old With Only $20 in 2020

    As the star of the hit ABC series Shark Tank, Mark Cuban knows a thing or two about what it takes to be a successful entrepreneur in the 21st century. When he’s not running his own businesses, he’s all about learning techniques in order to become—and stay—rich. The Dallas Mavericks owner recently sat down with… Read More »

  • Heavy Screen Time Changes Children’s Brains

    Editor’s Note: This article is a reprint. It was originally published December 27, 2018. Most people today live in a sea of radiofrequencies emitted from wireless technologies of all kinds, from routers to smartphones, tablets, baby monitors, TVs, appliances, smart meters and many more. According to many experts, chronic, heavy exposure could have severe repercussions… Read More »

  • Coronavirus: UK must prepare for second virus wave – health leaders

    Health leaders are calling for an urgent review to determine whether the UK is properly prepared for the “real risk” of a second wave of coronavirus. In an open letter published in the British Medical Journal, ministers were warned that urgent action would be needed to prevent further loss of life. The presidents of the… Read More »

  • FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes

    FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon)… Read More »

Copyright 2017
Iconic One Theme | Powered by Wordpress